Bayesian enrichment strategies for randomized discontinuation trials
From MaRDI portal
Publication:2894009
Recommendations
- Randomized discontinuation trials with binary outcomes
- Bayesian randomized clinical trials: A decision-theoretic sequential design
- A Bayesian Approach to the Design of Phase II Clinical Trials
- Decision-Theoretic Designs for Pre-Phase II Screening Trials in Oncology
- A signature enrichment design with Bayesian adaptive randomization
Cites work
- A new stochastic Gompertz diffusion process with threshold parameter: computational aspects and applications
- Bayes estimation of reliability for the two-parameter lognormal distribution
- Optimal Design via Curve Fitting of Monte Carlo Experiments
- Optimal Statistical Decisions
- Parameter Estimation in a Gompertzian Stochastic Model for Tumor Growth
- Statistical Methods for Eliciting Probability Distributions
- Stochastic Dominance among Log-Normal Prospects
Cited in
(6)- Randomized discontinuation trials with binary outcomes
- Optimizing parameters in clinical trials with a randomized start or withdrawal design
- Bayesian designs and the control of frequentist characteristics: a practical solution
- Estimation of Progression-Free Survival for All Treated Patients in the Randomized Discontinuation Trial Design
- Random norming AIDS analysis of non-linear regression models with sequential informative dose selection
- Robust meta‐analytic‐predictive priors in clinical trials with historical control information
This page was built for publication: Bayesian enrichment strategies for randomized discontinuation trials
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q2894009)